VC-backed Agile Therapeutics rolls out IPO
Agile Therapeutics has launched its IPO after pricing its over 9.16 million shares at $6 per share. The stock began trading Friday on the NASDAQ under the ticker symbol "AGRX." RBC Capital Markets and William Blair & Company are the lead underwriters. Based in Princeton, NJ, Agile Therapeutics develops prescription contraceptives. Its backers include Aisling Capital, Care Capital, Investor Growth Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.
23 May 2014•2 mins read
